The world of insurance compliance regulation is ever-changing. But that’s no reason to fret. Keep up with regulatory updates here in our live feed. With relevant changes to licensing, appointments, continuing education rules, and more, you can take a proactive approach to maintaining your organization’s compliance requirements.
Effective 14, 2025, New Mexico Pharmacy Benefits Manager's new and renewal applications will no longer be filed in SERFF. New and renewal applications will be handled through the Company Licensing Bureau. The application requirements may be found on the Company Licensing Bureau’s webpage: https://www.osi.state.nm.us/en/insurance-professionals/company-licensing/applying-for-admission-applications/
Please see the attachment for more information.
Effective November 14, 2025, Massachusetts will remove the following state-specific question from Nonresident License and Nonresident Renewal applications. - Are you legally blind?
Posted October 10.2025, Connecticut** **sent a reminder to surplus lines brokers that the diligent effort requirement remains in effect (to obtain coverage from admitted insurers before using the surplus lines market), except when coverage is placed through an unaffiliated wholesale surplus lines broker.
Under the general rule, a diligent effort is met if the coverage is on the Commissioner’s Exportable List or declined by three authorized insurers, with supporting documentation maintained for the policy term and one additional year.
Brokers are no longer required to submit quarterly diligent effort filings via OPTins, but must retain all relevant documentation and provide it upon request. All surplus lines premium tax filings and payments must continue to be submitted electronically through OPTins on the quarterly due dates of February 15, May 15, August 15, and November 15. Please see the following attachment for more information.
Effective November 14, 2025, Kansas will display Provisional Captive Insurance Company on the Producer Database. The Provisional Captive Insurance Company type will be eligible for appointments. Please see the attachment for the list of eligible Line of Business (LOB).
Posted October 9, 2025, Oklahoma announces that company appointment renewal invoices will be available for payment from November 25, 2025, to December 31, 2025. The termination deadline is November 14, 2025. The amount is $30 per appointment. Please see the attachment for more information.
Posted on October 3, 2025, the U.S. Virgin Islands published a bulletin detailing the examination policy, which covers: • Compliance standards • The timeframe for rescheduling after a failed attempt • The timeframe for obtaining a license upon passing
Please see the attachment for more information.
Effective October 1, 2025, North Carolina updated resident and nonresident licensing rules requiring Pharmacy Benefits Managers (PBMs) to become licensed. - A person or organization must obtain a license to operate as a pharmacy benefits manager. - To submit a complete application for initial or renewal PBM licensure, the following items must be filed in order: - A transmittal form; - A completed pharmacy benefits application form; - Biographical form(s) completed by principal officers; - All of the PBM's organizational documents, including any articles of incorporation, articles of association, partnership agreement, trade name certificate, or trust agreement, any other applicable documents, and all amendments to these documents; - The bylaws, rules, regulations, or similar documents regulating the PBM's internal affairs; - Annual financial statements or reports for the two most recent years that prove that the applicant is solvent and any other information the Commissioner may require to review the applicant's current financial condition; - A general description of the business operations, including information on staffing levels and activities proposed in North Carolina and nationwide; - A power of attorney duly executed by the PBM, if not domiciled in North Carolina, appointing the Commissioner as attorney for the PBM in and for North Carolina, upon whom process in any legal action or proceeding against the PBM on a cause of action arising in North Carolina may be served; and - Evidence of maintenance of a fidelity bond, errors and omissions liability insurance, or other security. - The description discussed above must provide details setting forth the PBM's capability for providing a sufficient number of experienced and qualified personnel in the areas of claims processing and record keeping. - Each applicant must make copies of all contracts with insurers or other persons using the PBM's services available for inspection. - An applicant or PBM must notify the Commissioner of any material modification within 30 business days of a change. Pharmacy Benefit Manager - Initial application fee: $2,000.00 - Annual renewal fee: $1,500.00 For more information on PBM licensing, visit NC DOI
Posted October 2, 2025, Georgia, has reached out to the Florida Surplus Lines Service Office (FSLSO) Slip+ team to conduct compliance review of Georgia-licensed surplus lines brokers. Compliance reviews will verify that: - All policies, endorsements, and cancellations are properly filed. - Premium taxes are accurately calculated, reported, and paid. - Broker records align with Georgia surplus lines laws and regulations. Please see the attachment for more information.
Alabama announces the company appointment renewal invoices will be available for payment from January 6, 2026 - March 1, 2026. The termination deadline is December 31, 2025. The late renewal windows are as follows:
- March 2, 2026 - March 31, 2026 - April 1, 2026 - April 30, 2026 - May 1, 2026 - May 31, 2026 Please see the attachment for fee information.
Posted October 3, 2025, New York added a new company to the list of Excess & Surplus lines (E&S) insurers, maintained by the Excess Line Association of New York (ELANY). Please see the attachment for more information.
Please try searching with another term
For the truly curious, subscribe to our updates and never miss a relevant regulatory update.